A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000 Aug 01; 48(1):7-16.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell
Disease-Free Survival
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Radiation Injuries
Time Factors
Treatment Failure

authors with profiles

ADAM S GARDEN